Literature DB >> 26516483

Headache disorders: differentiating and managing the common subtypes.

Fayyaz Ahmed1.   

Abstract

Headache is an extremely common symptom and collectively headache disorders are among the most common of the nervous system disorders, with a prevalence of 48.9% in the general population.(1) Headache affects people of all ages, races and socioeconomic status and is more common in women. Some headaches are extremely debilitating and have significant impact on an individual's quality of life, imposing huge costs to healthcare and indirectly to the economy in general. Only a small proportion of headache disorders require specialist input. The vast majority can be effectively treated by a primary care physician or generalist with correct clinical diagnosis that requires no special investigation. Primary headache disorders - migraine, tension headache and cluster headache - constitute nearly 98% of all headaches; however, secondary headaches are important to recognise as they are serious and may be life threatening. This article provides an overview of the most common headache disorders and discusses the red flag symptoms that help identify serious causes that merit urgent specialist referral. The current pathway of headache care in the UK is discussed with a view to proposing a model that might fit well in the financially constrained National Health Service (NHS) and with new NHS reforms. The role of the national society, the British Association for the Study of Headache, and the patient organisations such as Migraine Trust in headache education to the professionals and the general public in shaping headache care in the UK is described. The article concludes by summarising evidence-based management of common headache diagnoses.

Entities:  

Keywords:  Headache; cluster headache; medication overuse headache; migraine; tension headache

Year:  2012        PMID: 26516483      PMCID: PMC4590146          DOI: 10.1177/2049463712459691

Source DB:  PubMed          Journal:  Br J Pain        ISSN: 2049-4637


  41 in total

1.  New appendix criteria open for a broader concept of chronic migraine.

Authors:  J Olesen; M-G Bousser; H-C Diener; D Dodick; M First; P J Goadsby; H Göbel; M J A Lainez; J W Lance; R B Lipton; G Nappi; F Sakai; J Schoenen; S D Silberstein; T J Steiner
Journal:  Cephalalgia       Date:  2006-06       Impact factor: 6.292

2.  Analgesic-induced chronic headache: long-term results of withdrawal therapy.

Authors:  H C Diener; J Dichgans; E Scholz; S Geiselhart; W D Gerber; A Bille
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

3.  Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs.

Authors:  P Rossi; C Di Lorenzo; J Faroni; F Cesarino; G Nappi
Journal:  Cephalalgia       Date:  2006-09       Impact factor: 6.292

Review 4.  Burden of migraine. A review of its socioeconomic impact.

Authors:  G D Solomon; K L Price
Journal:  Pharmacoeconomics       Date:  1997       Impact factor: 4.981

5.  Medication-overuse headache in patients with cluster headache.

Authors:  K Paemeleire; A Bahra; S Evers; M S Matharu; P J Goadsby
Journal:  Neurology       Date:  2006-07-11       Impact factor: 9.910

6.  Management of medication overuse headache: 1-year randomized multicentre open-label trial.

Authors:  K Hagen; C Albretsen; S T Vilming; R Salvesen; M Grønning; G Helde; G Gravdahl; J-A Zwart; L J Stovner
Journal:  Cephalalgia       Date:  2008-09-24       Impact factor: 6.292

7.  Withdrawal syndrome after the double-blind cessation of caffeine consumption.

Authors:  K Silverman; S M Evans; E C Strain; R R Griffiths
Journal:  N Engl J Med       Date:  1992-10-15       Impact factor: 91.245

8.  EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force.

Authors:  S Evers; J Afra; A Frese; P J Goadsby; M Linde; A May; P S Sándor
Journal:  Eur J Neurol       Date:  2009-09       Impact factor: 6.089

9.  Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.

Authors:  Marcelo E Bigal; Daniel Serrano; Michael Reed; Richard B Lipton
Journal:  Neurology       Date:  2008-08-19       Impact factor: 9.910

10.  Regulation of prostaglandin synthesis in human vascular cells.

Authors:  B B Weksler
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

View more
  15 in total

1.  Guest Editorial.

Authors:  M S Chong
Journal:  Br J Pain       Date:  2012-08

Review 2.  Chronic Headache: a Review of Interventional Treatment Strategies in Headache Management.

Authors:  Ruchir Gupta; Kyle Fisher; Srinivas Pyati
Journal:  Curr Pain Headache Rep       Date:  2019-07-29

3.  Efficacy and safety of saroglitazar for the management of dyslipidemia: A systematic review and meta-analysis of interventional studies.

Authors:  Manik Chhabra; Kota Vidyasagar; Sai Krishna Gudi; Jatin Sharma; Rishabh Sharma; Muhammed Rashid
Journal:  PLoS One       Date:  2022-07-01       Impact factor: 3.752

4.  A migraine management training program for primary care providers: An overview of a survey and pilot study findings, lessons learned, and considerations for further research.

Authors:  Mia Minen; Ashna Shome; Audrey Halpern; Lori Tishler; K C Brennan; Elizabeth Loder; Richard Lipton; David Silbersweig
Journal:  Headache       Date:  2016-04-01       Impact factor: 5.887

5.  Spectrum of Disease and Prescription Pattern for Outpatients with Neurological Disorders: An Empirical Pilot Study in Bangladesh.

Authors:  Md Sahab Uddin; Abdullah Al Mamun; Md Asaduzzaman; Fakhrul Hosn; Mohammad Abu Sufian; Shinya Takeda; Oscar Herrera-Calderon; Mohamed M Abdel-Daim; G M Sala Uddin; Md Ali Asif Noor; Mst Marium Begum; Md Tanvir Kabir; Sonia Zaman; Md Shahid Sarwar; Md Mosiqur Rahman; Md Rajdoula Rafe; Md Farhad Hossain; Md Sarwar Hossain; Mohammed Ashraful Iqbal; Md Ataur Rahman Sujan
Journal:  Ann Neurosci       Date:  2017-10-31

6.  Vagus nerve stimulation for primary headache disorders: An anatomical review to explain a clinical phenomenon.

Authors:  Dylan Jozef Hendrik Augustinus Henssen; Berend Derks; Mats van Doorn; Niels Verhoogt; Anne-Marie Van Cappellen van Walsum; Peter Staats; Kris Vissers
Journal:  Cephalalgia       Date:  2019-02-20       Impact factor: 6.292

7.  Associations Between Headache-Free Days and Patient-Reported Outcomes Among Migraine Patients: A Cross-Sectional Analysis of Survey Data in Europe.

Authors:  Michael J Doane; Shaloo Gupta; Pamela Vo; Annik K Laflamme; Juanzhi Fang
Journal:  Pain Ther       Date:  2019-07-26

Review 8.  High Prevalence of Asthenopia among a Population of University Students.

Authors:  Hassan Hashemi; Mohammad Saatchi; Abbasali Yekta; Babak Ali; Hadi Ostadimoghaddam; Payam Nabovati; Mohamadreza Aghamirsalim; Mehdi Khabazkhoob
Journal:  J Ophthalmic Vis Res       Date:  2019-10-24

9.  Smartphone-Delivered Progressive Muscle Relaxation for the Treatment of Migraine in Primary Care: A Randomized Controlled Trial.

Authors:  Mia T Minen; Samrachana Adhikari; Jane Padikkala; Sumaiya Tasneem; Ashley Bagheri; Eric Goldberg; Scott Powers; Richard B Lipton
Journal:  Headache       Date:  2020-11-16       Impact factor: 5.887

Review 10.  Management of Childhood Headache in the Emergency Department. Review of the Literature.

Authors:  Umberto Raucci; Nicoletta Della Vecchia; Chiara Ossella; Maria Chiara Paolino; Maria Pia Villa; Antonino Reale; Pasquale Parisi
Journal:  Front Neurol       Date:  2019-08-23       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.